ST2 for the Management of Heart Failure - STADE-HF

NACompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

January 19, 2017

Primary Completion Date

April 26, 2019

Study Completion Date

April 26, 2019

Conditions
Heart FailureDiastolic Heart FailureSystolic Heart Failure Stage C
Interventions
OTHER

Conventional strategy

Conventional strategy to manage the patients with HF, following the international guidelines.

OTHER

ST2-guided strategy

patients wit ST2 over the median are targeted with higher doses of drugs with putative effects on fibrosis and anti HF pathophysiology

Trial Locations (1)

34295

University Regional Hospital Arnaud de Villeneuve, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02963272 - ST2 for the Management of Heart Failure - STADE-HF | Biotech Hunter | Biotech Hunter